Karaca Mehmet, Odabasoglu Fehmi, Kumtepe Yakup, Albayrak Abdulmecit, Cadirci Elif, Keles Osman N
Department of Obstetrics and Gynecology, Kafkas University School of Medicine Kars, Turkey.
Eur J Obstet Gynecol Reprod Biol. 2009 Jun;144(2):157-62. doi: 10.1016/j.ejogrb.2009.03.011. Epub 2009 Apr 16.
To evaluate the effects of erythropoietin (EPO) as an antioxidant and tissue protective agent and study the biochemical and histopathological changes in experimental ischemia and ischemia/reperfusion (I/R) injury in rat ovaries.
36 Adult female rats were used. The experimental groups were designed as Group 1: sham operation; Group 2: bilateral ovarian ischemia; and Group 3: 3 h period of ischemia followed by 3 h reperfusion. Group 4 rats were administered a 5000 IU dose of EPO, before 0.5 h of ischemia, and then bilateral ovarian ischemia was applied. After a 3 h period of ischemia, the bilateral ovaries were removed. In Group 5, a 3 h period of bilateral ovarian ischemia was applied. 2.5 h after the induction of ischemia, the rats were administered the same dose of EPO. At the end of a 3 h period of ischemia, 3h reperfusion was continued after the ovaries were removed. Group 6 underwent a sham operation after administration of 5000 IU/kg of EPO. After the experiments, superoxide dismutase (SOD), inducible nitric oxide synthase (iNOS), and myeloperoxidase (MPO) activity were determined, and histopathological changes were examined in all rat ovarian tissue.
Ischemia and ischemia/reperfusion increased the iNOS and MPO activity while decreasing the SOD activity significantly in comparison to the sham group. The 5000 IU/kg of EPO before ischemia and I/R reversed the trend in iNOS and MPO activities. The levels of SOD were decreased by the ischemia and I/R. The administration of EPO before ischemia and I/R treatments also reversed the trend in the SOD levels. In the ischemia/reperfusion plus EPO groups, though we observed minimal vascular dilation in the ovary stroma and some degenerative cell clusters, most of cellular structures did not show any pathological changes.
Administration of EPO is effective in reversing tissue damage induced by ischemia and/or ischemia/reperfusion in ovaries.
评估促红细胞生成素(EPO)作为抗氧化剂和组织保护剂的作用,并研究大鼠卵巢实验性缺血及缺血/再灌注(I/R)损伤中的生化和组织病理学变化。
使用36只成年雌性大鼠。实验组设计如下:第1组:假手术;第2组:双侧卵巢缺血;第3组:缺血3小时后再灌注3小时。第4组大鼠在缺血前0.5小时给予5000国际单位剂量的EPO,然后进行双侧卵巢缺血。缺血3小时后,切除双侧卵巢。第5组进行3小时的双侧卵巢缺血。缺血诱导2.5小时后,给大鼠给予相同剂量的EPO。在缺血3小时结束时,切除卵巢后继续进行3小时再灌注。第6组在给予5000国际单位/千克EPO后进行假手术。实验结束后,测定超氧化物歧化酶(SOD)、诱导型一氧化氮合酶(iNOS)和髓过氧化物酶(MPO)活性,并检查所有大鼠卵巢组织的组织病理学变化。
与假手术组相比,缺血和缺血/再灌注显著增加了iNOS和MPO活性,同时降低了SOD活性。缺血和I/R前给予5000国际单位/千克的EPO可逆转iNOS和MPO活性的变化趋势。缺血和I/R降低了SOD水平。缺血和I/R治疗前给予EPO也逆转了SOD水平的变化趋势。在缺血/再灌注加EPO组中,尽管我们观察到卵巢基质中有轻微的血管扩张和一些退行性细胞簇,但大多数细胞结构未显示任何病理变化。
给予EPO可有效逆转卵巢缺血和/或缺血/再灌注所致的组织损伤。